Select Page

On the Heels of the JAMA Study, PRF and Eiger BioPharmaceuticals Partner to Pursue FDA Approval of Lonafarnib

Collaboration marks the first submission for the treatment of Progeria. If approved, children may access drug by prescription instead of clinical trial!!

Read our latest press releases here:

Zoey and Carly getting their lonafarnib treatment during their latest clinical trial visit to Boston.

 

en_USEnglish